// Biotech and Pharma Therapeutics Biogen’s Aduhelm label far exceeds clinical trial population, study says. That could bring real-world surprises September 1, 2021 / Alzheimer’s / Drug Access / Aduhelm / Biogen While the chatter surrounding Biogen’s controversial Alzheimer’s med...